What It Is
A century-old molecule, studied today for the energy-hungry brain
Methylene blue is one of the most thoroughly characterized compounds in medicine — first synthesized in 1876 and used clinically for well over a century. It is FDA-approved for specific conditions such as methemoglobinemia and has a long, well-documented safety record at appropriate doses.
What has drawn renewed scientific interest is its behavior at low doses. Rather than acting on a single receptor, methylene blue works inside the mitochondria — the structures that produce cellular energy — as an electron carrier that supports cell respiration and helps reduce oxidative stress.
Because neurons are exceptionally energy-dependent, researchers have spent the last several decades studying whether low-dose methylene blue can influence memory, attention, and brain metabolism. At Dr. David Wellness, it is offered only as a physician-formulated, physician-supervised compounded oral preparation — never as an unsupervised supplement.
The Dr. David Wellness preparation
Compounded oral tablet / capsule
USP pharmaceutical-grade
Low-dose, individualized by physician
Licensed compounding pharmacy
Requires intake & physician review
Board-certified physician
How It Works
The mechanism: cellular energy, not stimulation
Methylene blue is not a stimulant. Its studied effects center on how efficiently brain cells produce and protect their own energy supply.
01
Mitochondrial electron cycling
At low concentrations, methylene blue can accept and donate electrons within the mitochondrial electron transport chain, supporting ATP production — including a route around certain points of dysfunction.
02
Antioxidant support
By improving the efficiency of cellular respiration, low-dose methylene blue has been studied for its capacity to reduce the reactive oxygen species that accumulate as a byproduct of energy production.
03
Cytochrome c oxidase activity
Research has focused on methylene blue’s interaction with cytochrome c oxidase, a key respiratory enzyme — the same metabolic pathway linked in studies to memory consolidation and neuronal resilience.
The Research
What the published science actually shows
Below are peer-reviewed sources on low-dose methylene blue, brain metabolism, and cognition — including a balanced view of what is established and what is still preliminary.
2016
Single low dose linked to improved memory retrieval in healthy adults
In a randomized, double-blind, placebo-controlled functional MRI study of 26 healthy adults, a single low oral dose of methylene blue increased MRI response in brain regions tied to attention and short-term memory, and was associated with a roughly 7% increase in correct responses during memory retrieval.
Radiology
2012
Neurometabolic mechanisms for memory enhancement and neuroprotection
A widely cited review describing how low-dose methylene blue acts as a mitochondrial electron cycler with a hormetic (dose-dependent) profile, and summarizing preclinical evidence for memory enhancement and neuroprotection against mitochondrial dysfunction.
Progress in Neurobiology
2017
From mitochondrial function to neuroprotection — an emerging role for methylene blue
A review of in vitro and animal-model research reporting effects of methylene blue on neurodegeneration across models of stroke, cerebral ischemia, Alzheimer’s, Parkinson’s, and traumatic brain injury.
Molecular Neurobiology
2020
Mitochondria as a target for neuroprotection: methylene blue and photobiomodulation
A review examining methylene blue alongside other mitochondria-targeted approaches, noting beneficial effects on mitochondrial function, oxidative damage, and inflammation in animal models — while emphasizing that human data remain limited.
Translational Neurodegeneration
An honest read of the evidence
The most encouraging human findings to date involve acute, short-term effects in small studies of healthy adults. Much of the neuroprotection research is preclinical — conducted in cell and animal models — and does not by itself establish disease-prevention benefits in people.
It is also worth knowing that large Phase 3 trials of methylene blue derivatives for Alzheimer’s disease did not meet their primary endpoints, which underscores how much remains unproven. Methylene blue is not FDA-approved for cognitive enhancement, neuroprotection, or brain health, and any use for these purposes is considered off-label and investigational.
Is It Right For You
Methylene blue is not for everyone — and that matters
A core purpose of the intake review is to separate good candidates from people for whom methylene blue could be unsafe.
May be a candidate
- Healthy adults focused on cognitive performance, mental clarity, and energy
- Interested in a physician-supervised, low-dose, pharmaceutical-grade preparation
- Not taking serotonergic medications and willing to complete a full medication review
- Comfortable with a program grounded in mechanism and emerging research rather than guaranteed outcomes
Should not use methylene blue
- Anyone taking SSRIs, SNRIs, MAOIs or other serotonergic medications — serious interaction risk
- People with G6PD deficiency — risk of hemolytic anemia
- Women who are pregnant or may become pregnant
- Anyone whose physician review identifies a conflicting medication or health condition
Important safety information
Serotonin syndrome risk
G6PD deficiency
Pregnancy
Other considerations
How To Begin
A clear, physician-led pathway
There is no “add to cart” for methylene blue here. Access runs through a clinical process — by design.
-
Complete intake
Fill out the secure online form covering your health history, current medications, and goals.
-
Physician review
A board-certified physician reviews your intake and screens for interactions and contraindications.
-
Compounded & dispensed
If appropriate, an individualized low-dose preparation is compounded and shipped with clear instructions.
-
Ongoing oversight
Follow-up and physician access remain available so your program can be adjusted or stopped as needed.
Common Questions
Methylene blue, answered
-
Methylene blue is a well-characterized compound first synthesized in the 1800s and long used in medicine. At low doses it acts within the mitochondria as an electron carrier, supporting cellular energy production and helping reduce oxidative stress. Because neurons are highly energy-dependent, researchers have studied low-dose methylene blue for its effects on memory, attention, and brain metabolism. At Dr. David Wellness it is offered only as a physician-formulated, physician-supervised compounded preparation.
-
No. Methylene blue is FDA-approved for specific medical conditions such as methemoglobinemia, but it is not FDA-approved for cognitive enhancement, neuroprotection, or general brain health. Use for those purposes is considered off-label and investigational — which is why a physician evaluation is required before it can be prescribed.
-
Generally no. Methylene blue is a potent MAO-A inhibitor and can cause serotonin syndrome — a serious, potentially life-threatening reaction — when combined with SSRIs, SNRIs, MAOIs, and other serotonergic medications. Anyone taking these medications should not use methylene blue without explicit physician direction. Screening for these medications is a core part of the intake review.
-
The most promising human evidence involves acute, short-term effects in small studies of healthy adults — for example, a randomized placebo-controlled MRI study linking a single low dose to improved memory retrieval. Much of the neuroprotection research is preclinical (cell and animal models). Large trials of methylene blue derivatives for Alzheimer’s disease did not meet their primary endpoints. The science is genuinely interesting but still emerging, and that context is part of every physician consultation. See the research section above for sources.
-
Methylene blue follows a hormetic dose-response, meaning low and high doses can have opposite effects — so dosing matters a great deal. The Dr. David Wellness preparation is low-dose and individualized by the physician based on your intake. Dosing instructions are provided with your compounded preparation; this page intentionally does not publish a dosing protocol.
-
Complete the secure online intake form. A physician reviews your health history, current medications, and goals to determine whether compounded methylene blue is appropriate for you. If you’re a candidate, an individualized low-dose preparation is dispensed by a compounding pharmacy with clear instructions and follow-up.
Start with a physician review
Find out whether physician-supervised, low-dose compounded methylene blue is an appropriate fit for your brain-health goals.
